| 2026-08-06 | Deck | Second-Quarter 2026 Earnings Presentation |
| 2026-08-06 | Press release | Press release · Q2 2026 · Aug 2026 |
| 2026-08-06 | Press release | Press release · Q2 2026 · Aug 2026 |
| 2026-08-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-01 | Deck | Investor presentation · Q2 2026 · Aug 2026 |
| 2026-07-23 | Press release | Insmed Second-Quarter 2026 Financial Results Conference Call |
| 2026-07-16 | Deck | Earnings presentation · Q2 2026 · Jul 2026 |
| 2026-07-16 | Press release | Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation |
| 2026-07-16 | 8-K | Form 8-K, Item 7.01 |
| 2026-06-23 | Press release | Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory |
| 2026-06-04 | Press release | Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
| 2026-05-27 | Press release | Insmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference |
| 2026-05-15 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-07 | Deck | Earnings presentation · Q1 2026 · May 2026 |
| 2026-05-07 | Press release | Press release · Q1 2026 · May 2026 |
| 2026-05-07 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-07 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-05-06 | Press release | Press release · May 2026 |
| 2026-05-04 | Press release | Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE |
| 2026-05-01 | Deck | Download the Investor Presentation · Q1 2026 |
| 2026-04-30 | Press release | Insmed to Present at May 2026 Investor Conferences |
| 2026-04-23 | Press release | Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 |
| 2026-04-07 | Press release | Insmed Provides Clinical Update on Phase 2b CEDAR Study |
| 2026-04-07 | 8-K | Form 8-K, Item 7.01 |
| 2026-04-01 | Proxy | Definitive proxy statement |
| 2026-03-24 | Annual report | Download 2025 Annual Report |
| 2026-03-23 | Press release | Press release · Mar 2026 |
| 2026-03-23 | Deck | Investor presentation · Mar 2026 |
| 2026-03-23 | 8-K | Form 8-K, Item 7.01 |
| 2026-02-19 | Press release | Press release · Q4 2025 · Feb 2026 |
| 2026-02-19 | Deck | Earnings presentation · Q4 2025 · Feb 2026 |
| 2026-02-19 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-19 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-19 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-12 | Deck | Third-Quarter 2025 Earnings Presentation |
| 2026-01-09 | 8-K | Form 8-K, Item 7.01 |
| 2025-12-17 | 8-K | Form 8-K, Item 7.01 |
| 2025-11-18 | 8-K | Form 8-K, Item 7.01 |
| 2025-10-30 | 8-K | Form 8-K, Item 2.02 results |